Paid Clinical Trials Arlington

Discover 1,700 paid clinical trials in Arlington, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 1,700

DETEC® EsteraseDETEC® Esterase for Screening Wound Infection at Point of Care

Recruiting

Sponsor:

Progenitec Inc.

Location:

Arlington TX

Code:

NCT04614870

Conditions

Diabetic Foot Ulcer

Venous Leg Ulcer

Pressure Ulcer

Eligibility Criteria

Sex: All

Age: 21+

Healthy Volunteers: Not accepted

Interventions

DETEC® Esterase

Blood PressureReducing Blood Pressure in Mid-life Adult Binge Drinkers

Recruiting

Sponsor:

The University of Texas at Arlington

Location:

Arlington TX

Code:

NCT05522075

Conditions

Alcohol Drinking

Binge Drinking

Blood Pressure

Alcohol Abstinence

Aging

Eligibility Criteria

Sex: All

Age: 50 - 64

Healthy Volunteers: Accepted

Interventions

Exercise Training

Alcohol Abstinence Intervention

ElafibranorA Long-Term Study of Elafibranor in Adult Participants With Primary Biliary Cholangitis

Recruiting

PHASE3

Sponsor:

Ipsen

Location:

Arlington TX, Dallas TX, Waco TX, Austin TXshow 21 more

Code:

NCT06016842

Conditions

Primary Biliary Cholangitis (PBC)

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Elafibranor

Matched 80 mg placebo

eCoinA Real World Study of eCoin for Urgency Urinary Incontinence: Post Approval Evaluation (RECIPE)

Recruiting

Sponsor:

Valencia Technologies Corporation

Location:

Arlington TX, Shreveport LA, Houston TX, Little Rock ARshow 15 more

Code:

NCT05685433

Conditions

Overactive Bladder

Urge Incontinence

Incontinence, Urinary

Urinary Urge Incontinence

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

eCoin Tibial Nerve Stimulation

BEM/RZR vs. SOF/VELC-BEYOND: Efficacy and Safety of BEM/RZR vs. SOF/VEL in Subjects With Chronic HCV

Recruiting

PHASE3

Sponsor:

Atea Pharmaceuticals, Inc.

Location:

Arlington TX, Plano TX, San Antonio TX, Tulsa OKshow 15 more

Code:

NCT06868264

Conditions

HEPATITIS C VIRUS CHRONIC INFECTION

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Bemnifosbuvir-Ruzasvir (BEM/RZR)

Sofosbuvir-Velpatasvir (SOF/VEL)

HM15211Study to Evaluate Efficacy, Safety and Tolerability of HM15211(efocipegtrutide) in Subjects

Recruiting

PHASE2

Sponsor:

Hanmi Pharmaceutical Company Limited

Location:

Arlington TX, Dallas TX, Garland TX, Austin TXshow 27 more

Code:

NCT04505436

Conditions

NASH - Nonalcoholic Steatohepatitis

Eligibility Criteria

Sex: All

Age: 18 - 70

Healthy Volunteers: Not accepted

Interventions

HM15211

Placebo of HM15211

Bimekizumab vs. UstekinumabA Study to Evaluate the Efficacy and Safety of Bimekizumab Compared to Ustekinumab in Children and Adolescents From 6 Years to Less Than 18 Years of Age With Moderate to Severe Plaque Psoriasis

Recruiting

PHASE3

Sponsor:

UCB Biopharma SRL

Location:

Arlington TX, Dallas TX, Indianapolis IN, Charleston SCshow 8 more

Code:

NCT06425549

Conditions

Moderate to Severe Plaque Psoriasis

Eligibility Criteria

Sex: All

Age: 6 - 17

Healthy Volunteers: Not accepted

Interventions

bimekizumab

ustekinumab

placebo

Amlitelimab with CorticosteroidsA Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab on Background Topical Corticosteroids Therapy in Participants Aged 12 Years and Older With Moderate-to-severe AD Who Have Had an Inadequate Response to Prior Biologic Therapy or an Oral JAK Inhibitor

Recruiting

PHASE3

Sponsor:

Sanofi

Location:

Arlington TX, Dallas TX, North Little Rock AR, Metairie LAshow 35 more

Code:

NCT06241118

Conditions

Dermatitis Atopic

Eligibility Criteria

Sex: All

Age: 12+

Healthy Volunteers: Not accepted

Interventions

Amlitelimab

Placebo

Topical corticosteroids

Topical tacrolimus or pimecrolimus

PioglitazonePioglitazone to Reduce Sympathetic Overactivity in CKD Patients

Recruiting

Sponsor:

The University of Texas at Arlington

Location:

Arlington TX, Dallas TX

Code:

NCT03471117

Conditions

Chronic Kidney Diseases

Eligibility Criteria

Sex: All

Age: 35 - 70

Healthy Volunteers: Not accepted

Interventions

Pioglitazone

Placebo

AmlitelimabA Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab Monotherapy Compared With Placebo in Participants Aged 12 Years and Older With Moderate-to-severe Atopic Dermatitis (COAST 2)

Recruiting

PHASE3

Sponsor:

Sanofi

Location:

Arlington TX, Dallas TX, Houston TX, Missouri City TXshow 32 more

Code:

NCT06181435

Conditions

Dermatitis Atopic

Eligibility Criteria

Sex: All

Age: 12+

Healthy Volunteers: Not accepted

Interventions

Amlitelimab

Placebo

Paid Clinical Trials Arlington

Filter results

DETEC® EsteraseDETEC® Esterase for Screening Wound Infection at Point of Care

Blood PressureReducing Blood Pressure in Mid-life Adult Binge Drinkers

ElafibranorA Long-Term Study of Elafibranor in Adult Participants With Primary Biliary Cholangitis

eCoinA Real World Study of eCoin for Urgency Urinary Incontinence: Post Approval Evaluation (RECIPE)

BEM/RZR vs. SOF/VELC-BEYOND: Efficacy and Safety of BEM/RZR vs. SOF/VEL in Subjects With Chronic HCV

Interested in new trials?

HM15211Study to Evaluate Efficacy, Safety and Tolerability of HM15211(efocipegtrutide) in Subjects

Bimekizumab vs. UstekinumabA Study to Evaluate the Efficacy and Safety of Bimekizumab Compared to Ustekinumab in Children and Adolescents From 6 Years to Less Than 18 Years of Age With Moderate to Severe Plaque Psoriasis

PioglitazonePioglitazone to Reduce Sympathetic Overactivity in CKD Patients

AmlitelimabA Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab Monotherapy Compared With Placebo in Participants Aged 12 Years and Older With Moderate-to-severe Atopic Dermatitis (COAST 2)